Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
OBX · NASDAQ · Pharmaceutical Preparations · No 10-K yet
$12.21+0.14 (+1.16%)
Close of Nov 18, 2026, vs Nov 17 · end-of-day, not a live quote
Obsidian Therapeutics (OBX) · oqro.io/stocks/OBX · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
Everything reported about this company, newest first. Each line shows the dates that matter for its source.
5%+ stake · Stake as of Sep 30, 2026 · Filed Nov 16, 2026
Deep Track Capital, LP cut its OBX stake below 5% (3.4%)SourceFund moves · Holdings as of Sep 30, 2026 (Q3 2026) · Filed Nov 6, 2026
Alphabet (corporate stakes) disclosed a new position in OBX for Q3 2026Source5%+ stake · Stake as of Sep 28, 2026 · Filed Oct 5, 2026
Paradigm BioCapital Advisors LP now owns 6.6% of OBX as a passive investorSource